Clinical Trials Directory

Trials / Completed

CompletedNCT03041818

Development of Horse-Riding Program Model for Children With Cerebral Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
The Catholic University of Korea · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to develop healing riding algorithm applicable in rural riding centers and to apply this to children with cerebral palsy.

Detailed description

Horseback riding activities in Korea's riding centers have mostly centered on physical rehabilitation for children with special needs, including those with cerebral palsy, mental disabilities, and autism, with the program conducted by certified equine-assisted therapy instructors. However, there is no definite way to assess the ability of children for horseback riding and no standard riding program. Therefore, developing a assessment and program algorithm for healing horseback riding is expected to contribute to providing more activities for children with special needs and also for general people. Children older than 4 years old or adolescent with cerebral palsy who voluntarily want to enroll this study would be enrolled. Participants have 2 times of 30-minute horse riding program for 8 weeks, total 16 times of riding program in a local horse riding center. Sample size assessment: Calculating for 20% of drop out, 16 patients were calculated to apply the assessment and applicable program. Drop out: missing more than 2 lessons of horse-riding Plan for missing data: not included Statistical analysis plan: paired t-test for the outcome measures

Conditions

Interventions

TypeNameDescription
BEHAVIORALHorseback riding therapyApply 30 minutes/session, twice a week for 8 weeks of horseback riding therapy (provided with 1 horse rider, 2 side walkers)

Timeline

Start date
2017-03-14
Primary completion
2017-10-31
Completion
2017-10-31
First posted
2017-02-03
Last updated
2018-05-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03041818. Inclusion in this directory is not an endorsement.